Specialties
General MSK
Specialties
Orthopaedics
Specialties
Shoulder
160 results found in 5ms
ChondroFiller Injection Evidence Patients Should WeighChondroFiller Injection Evidence Patients Should Weigh
Injected collagen scaffold improves focal cartilage defects by 30 IKDC points — exceeding the minimum clinically important difference — sustaining benefit 2–5 years, though only in joints without advanced osteoarthritis; evidence is limited to small cohorts without a large randomised controlled trial.Injected collagen scaffold improves focal cartilage defects by 30 IKDC points — exceeding the minimum clinically important difference — sustaining benefit 2–5 years, though only in joints without advanced osteoarthritis; evidence is limited to small cohorts without a large randomised controlled trial.
ChondroFiller™ durability compared with ArthrosamidChondroFiller™ durability compared with Arthrosamid
ChondroFiller™ recruits the patient's own progenitor cells to build new cartilage tissue within a collagen scaffold. Three-year published follow-up shows mean IKDC scores of 80 — a 32.4-point improvement from baseline — with durability reported to extend beyond five years.ChondroFiller™ recruits the patient's own progenitor cells to build new cartilage tissue within a collagen scaffold. Three-year published follow-up shows mean IKDC scores of 80 — a 32.4-point improvement from baseline — with durability reported to extend beyond five years.
Who qualifies for ChondroFiller injectionWho qualifies for ChondroFiller injection
ChondroFiller injects a collagen scaffold into focal cartilage lesions—typically grade III–IV defects under 6 cm²—to recruit the patient's progenitor cells for repair rather than replacing tissue artificially.ChondroFiller injects a collagen scaffold into focal cartilage lesions—typically grade III–IV defects under 6 cm²—to recruit the patient's progenitor cells for repair rather than replacing tissue artificially.
Ten-Year Success Rates for OATS MosaicplastyTen-Year Success Rates for OATS Mosaicplasty
Ten-year success rates for OATS mosaicplasty span 72–89% in young, active patients; failure rates drop to 12.5–14% in optimal candidates (under 40, lesion under 3 cm²) but rise to 38–40% in older patients with larger defects.Ten-year success rates for OATS mosaicplasty span 72–89% in young, active patients; failure rates drop to 12.5–14% in optimal candidates (under 40, lesion under 3 cm²) but rise to 38–40% in older patients with larger defects.
Choosing between ACI and MACI for cartilage repairChoosing between ACI and MACI for cartilage repair
MACI cartilage grafts show 90% fill at two years but decline to 49% by ten years; 73% become fibrocartilage rather than the hyaline cartilage needed for durability.MACI cartilage grafts show 90% fill at two years but decline to 49% by ten years; 73% become fibrocartilage rather than the hyaline cartilage needed for durability.
ChondroFiller injection versus cartilage surgeryChondroFiller injection versus cartilage surgery
ChondroFiller injection achieves 30 IKDC improvement with 3–8% reoperation and 0% complications; microfracture carries 41% reoperation rates with declining long-term outcomes; ACI/MACI matches functional gains but brings 17% complications and 37% reoperation.ChondroFiller injection achieves 30 IKDC improvement with 3–8% reoperation and 0% complications; microfracture carries 41% reoperation rates with declining long-term outcomes; ACI/MACI matches functional gains but brings 17% complications and 37% reoperation.
What separates ChondroFiller from Liquid CartilageWhat separates ChondroFiller from Liquid Cartilage
ChondroFiller is a single collagen scaffold delivered two ways: as an outpatient injection alone, or combined with patient-derived cells under the clinical brand Liquid Cartilage™. Naming overlap at clinics obscures which is being offered.ChondroFiller is a single collagen scaffold delivered two ways: as an outpatient injection alone, or combined with patient-derived cells under the clinical brand Liquid Cartilage™. Naming overlap at clinics obscures which is being offered.
MACI recovery and return to sportMACI recovery and return to sport
MACI recovery takes twelve to eighteen months before high-impact sport. Most patients return to some sport, but only one-third reach their pre-injury level — a gap significantly driven by kinesiophobia, which clinical teams can screen and address through sports psychology support.MACI recovery takes twelve to eighteen months before high-impact sport. Most patients return to some sport, but only one-third reach their pre-injury level — a gap significantly driven by kinesiophobia, which clinical teams can screen and address through sports psychology support.
Meniscus tear: which specialist to see and whether surgery is neededMeniscus tear: which specialist to see and whether surgery is needed
The meniscus's blood supply determines whether a tear can heal: the outer third can regenerate, the inner zone cannot. For degenerative tears, surgery does not improve outcomes and increases osteoarthritis progression; conservative physiotherapy leads to recovery within four to eight weeks.The meniscus's blood supply determines whether a tear can heal: the outer third can regenerate, the inner zone cannot. For degenerative tears, surgery does not improve outcomes and increases osteoarthritis progression; conservative physiotherapy leads to recovery within four to eight weeks.
Single-stage vs two-stage ACI for cartilage repairSingle-stage vs two-stage ACI for cartilage repair
Traditional two-stage ACI involves two general anaesthetics separated by a four-to-six-week cell culture period; STACI performs both stages in a single theatre session, requiring one general anaesthetic and eliminating the inter-stage gap.Traditional two-stage ACI involves two general anaesthetics separated by a four-to-six-week cell culture period; STACI performs both stages in a single theatre session, requiring one general anaesthetic and eliminating the inter-stage gap.
Who qualifies for ChondroFiller Liquid Cartilage injectionWho qualifies for ChondroFiller Liquid Cartilage injection
ChondroFiller is an outpatient ultrasound-guided injection—not surgery—of acellular collagen that recruits the patient's own progenitor cells to regenerate cartilage damage, without upper age or defect-size limits.ChondroFiller is an outpatient ultrasound-guided injection—not surgery—of acellular collagen that recruits the patient's own progenitor cells to regenerate cartilage damage, without upper age or defect-size limits.
ChondroFiller injection costs in the UK and EuropeChondroFiller injection costs in the UK and Europe
ChondroFiller costs £3,000–£8,000 in the UK, scaled by defect size, delivered as an ultrasound-guided outpatient injection with no surgery or anaesthetic.ChondroFiller costs £3,000–£8,000 in the UK, scaled by defect size, delivered as an ultrasound-guided outpatient injection with no surgery or anaesthetic.
160 results found in 5ms